CGG: Information on the total number of voting rights and shares
CGG A French société anonymewith a share capital of € 7,136,762Registered office: 27 avenue Carnot, 91300 Massy, FranceEvry Trade and […]
Nasdaq European Markets sustains its strong position in the SME listings and sustainable debt market in 2023
Nasdaq European Markets welcomed 33 listings, including 7 initial public offerings (IPOs), raising a total of EUR 431 million risk […]
LIFT Announces Changes to its Board of Directors
VANCOUVER, British Columbia, Jan. 08, 2024 (GLOBE NEWSWIRE) — Li-FT Power Ltd. (“LIFT” or the “Company”) (TSXV: LIFT) (OTCQX: LIFFF) […]
QIAGEN receives FDA clearance of NeuMoDx CT/NG Assay for use on both NeuMoDx 96 and 288 Molecular Systems
Germantown, Maryland, and Venlo, the Netherlands, Jan. 08, 2024 (GLOBE NEWSWIRE) — QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today […]
Shell fourth quarter 2023 update note
The following is an update to the fourth quarter 2023 outlook and gives an overview of our current expectations for […]
argenx Highlights 2024 Strategic Priorities
Reported $1.2 billion in preliminary* full-year 2023 global net product sales Submitted sBLA to FDA for VYVGART®Hytrulo for CIDP with […]
Pharming Group announces updated full year 2023 guidance and Joenja® U.S. launch update
Expect 10% growth in RUCONEST® revenue, significantly exceeding prior guidance Expect Joenja® revenues of approximately US$18 million with 81 patients […]
Vivoryon Therapeutics N.V. to Host Investor Meetings in January 2024
Vivoryon Therapeutics N.V. to Host Investor Meetings in January 2024 Halle (Saale) / Munich, Germany, January 8, 2024 – Vivoryon […]
Ascendis Pharma Introduces Vision 2030
Strategic roadmap to achieve blockbuster status for multiple products and expandthe Company’s engine for future innovation COPENHAGEN, Denmark, Jan. 07, […]
Singular Genomics Reports Instrument Shipments and Preliminary Unaudited Fourth Quarter 2023 Revenue
SAN DIEGO, Jan. 07, 2024 (GLOBE NEWSWIRE) — Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing […]
